Bard Hernia Mesh Trials Pushed Back to September 2020, As Number of Lawsuits Continue to Rise

As hundreds of additional Bard hernia mesh lawsuits continue to be filed each month, parties will have to wait a bit longer before the first federal bellwether trials begin, as the U.S. District Judge presiding over the litigation indicates the earliest a jury will be convened to hear evidence is September 2020, amid the on-going COVID-19 pandemic.

Bard currently faces more than 6,800 product liability lawsuits filed throughout the federal court system, each involving plaintiffs who suffered painful and debilitating complications following hernia repair procedures where Bard’s Ventralex, Ventralight, Perfix, 3DMax and other patch designs were used. However, as hernia mesh lawyers continue to review and file claims in the coming months and years, it is widely expected the size of the litigation will continue to grow.

According to recent court records, about 500 new cases are being filed each month throughout the federal court system, and the total number of Bard hernia mesh cases may near 10,000 by the end of the year.

Hernia Mesh Lawsuits

Did you or a loved one receive a hernia mesh?

Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery.

Learn More About this Lawsuit See If You Qualify For Compensation

Given common questions of fact and law raised in the complaints, the federal judiciary has consolidated the litigation before U.S. District Judge Edmund A. Sargus in the Southern District of Ohio, for coordinated discovery and a series of early trial dates designed to help the parties gauge the relative strengths and weaknesses of their claims, as well as how juries are likely to respond to certain evidence and testimony that will be repeated throughout the lawsuits.

In January, Judge Sargus identified specific plaintiffs selected for the first Bard hernia mesh jury trials, which were expected to begin in May 2020, July 2020 and September 2020. However, as jury trials nationwide are being postponed, the Court issued orders in March which pushed back the start of the first two cases until July 2020 and September 2020.

According to a new pretrial order (PDF) issued on April 24, Judge Sargus announced the first trial will now not start until September 2020, but could be delayed further as both parties initially requested that the trials be delayed until 2021 due to the impact of the COVID-19 pandemic.

“The Court will continue to monitor the situation closely and be in touch with the parties about the September 29, 2020 trial date, and may reconsider the decision to hold the Johns trial on that date if the situation does not improve,” Judge Sargus wrote about the first scheduled bellwether trial.

“The Court will also update the parties at the next status conference regarding dates for the Milanesi and Stinson trials,” referring to the second and third cases selected for the bellwether process.

On the same day, the Court sent out a notice (PDF) setting the next telephone conference for May 21.

While the outcomes of these early bellwether trial dates will not be binding on other Bard hernia patch cases, they are expected to have a substantial impact on any hernia mesh settlements that Bard may offer to avoid thousands of individual trials being set for trial nationwide.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 2 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted 2 days ago)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.